3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione

3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione Struktur
105774-49-0
CAS-Nr.
105774-49-0
Englisch Name:
3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione
Synonyma:
3-(4-Chloro-phenyl)-8-methyl-1,4-dihydro-8H-1,2,4a,6,8,9-hexaaza-fluorene-5,7-dione;3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione;[1,2,4]Triazino[3,4-f]purine-6,8(7H,9H)-dione, 3-(4-chlorophenyl)-1,4-dihydro-9-methyl-
CBNumber:
CB52021684
Summenformel:
C14H11ClN6O2
Molgewicht:
330.73
MOL-Datei:
105774-49-0.mol

3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione Eigenschaften

Dichte
1.76±0.1 g/cm3(Predicted)
pka
7.60±0.40(Predicted)

Sicherheit

3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione Chemische Eigenschaften,Einsatz,Produktion Methoden

3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
PHARMEKS Ltd. --
sales@pharmeks.com Finland 6350 50
LIFE CHEMICALS, formerly I.F. Lab --
vasily.pinchuk@lifechemicals.com Canada 6706 69
Princeton BioMolecular Research, Inc. --
info@princetonbio.com United States 6935 51
Interbioscreen Ltd. --
screen@ibscreen.chg.ru Finland 6178 60
Specs --
info@specs.net The Netherlands 6835 70

  • 3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione
  • 3-(4-Chloro-phenyl)-8-methyl-1,4-dihydro-8H-1,2,4a,6,8,9-hexaaza-fluorene-5,7-dione
  • [1,2,4]Triazino[3,4-f]purine-6,8(7H,9H)-dione, 3-(4-chlorophenyl)-1,4-dihydro-9-methyl-
  • 105774-49-0
  • C14H11ClN6O2
Copyright 2019 © ChemicalBook. All rights reserved